Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Philip

Showing results (381-390 of 441) with videos related to

Pageof 45
Sort By:
British Journal of Cancer|January 1, 1997
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expressionV Combaret, N Gross, C Lasset, et al.
Minerva Pediatrica|October 15, 1987
[Autologous bone marrow transplantation in Burkitt's lymphoma]M de Terlizzi, T Philip, P Biron, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Non-metastatic Ewing's sarcoma of the ribs: the French Society of Pediatric Oncology ExperienceN Sirvent, J Kanold, C Levy, et al.
Respiratory Medicine|July 15, 2004
Simple aspiration versus chest-tube insertion in the management of primary spontaneous pneumothorax: a systematic reviewA Devanand, M S Koh, T H Ong, et al.
European Cytokine Network|August 1, 1990
Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapyM Favrot, R Capdeville, V Combaret, et al.
Cancer Biotherapy|January 1, 1993
A comparison of 2 modes of administration of recombinant interleukin-2: continuous intravenous infusion alone versus subcutaneous administration plus interferon alpha in patients with advanced renal cell carcinomaP A Palmer, J Atzpodien, T Philip, et al.
Bulletin Du Cancer|January 17, 2002
[School reinsertion of children treated for tumors of the brain: experience of the Léon-Bérard center]D Frappaz, P Marec-Bérard, M Schell, et al.
Bone Marrow Transplantation|January 1, 1991
RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind studyN C Gorin, B Coiffier, M Hayat, et al.
Journal of Biological Response Modifiers|April 1, 1990
Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinomaM C Favrot, V Combaret, S Negrier, et al.
Bulletin Du Cancer|January 1, 1988
[Intensive chemotherapy and bone marrow grafting during the consolidation phase of stage IV neuroblastoma]T Philip, J M Zucker, J L Bernard, et al.
Pageof 45

Showing results (381-390 of 441) with videos related to

Sort By:
Pageof 45
British Journal of Cancer|January 1, 1997
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expressionV Combaret, N Gross, C Lasset, et al.
Minerva Pediatrica|October 15, 1987
[Autologous bone marrow transplantation in Burkitt's lymphoma]M de Terlizzi, T Philip, P Biron, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Non-metastatic Ewing's sarcoma of the ribs: the French Society of Pediatric Oncology ExperienceN Sirvent, J Kanold, C Levy, et al.
Respiratory Medicine|July 15, 2004
Simple aspiration versus chest-tube insertion in the management of primary spontaneous pneumothorax: a systematic reviewA Devanand, M S Koh, T H Ong, et al.
European Cytokine Network|August 1, 1990
Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapyM Favrot, R Capdeville, V Combaret, et al.
Cancer Biotherapy|January 1, 1993
A comparison of 2 modes of administration of recombinant interleukin-2: continuous intravenous infusion alone versus subcutaneous administration plus interferon alpha in patients with advanced renal cell carcinomaP A Palmer, J Atzpodien, T Philip, et al.
Bulletin Du Cancer|January 17, 2002
[School reinsertion of children treated for tumors of the brain: experience of the Léon-Bérard center]D Frappaz, P Marec-Bérard, M Schell, et al.
Bone Marrow Transplantation|January 1, 1991
RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind studyN C Gorin, B Coiffier, M Hayat, et al.
Journal of Biological Response Modifiers|April 1, 1990
Functional and immunophenotypic modifications induced by interleukin-2 did not predict response to therapy in patients with renal cell carcinomaM C Favrot, V Combaret, S Negrier, et al.
Bulletin Du Cancer|January 1, 1988
[Intensive chemotherapy and bone marrow grafting during the consolidation phase of stage IV neuroblastoma]T Philip, J M Zucker, J L Bernard, et al.
Pageof 45